Hepcidin is the master hormone governing systemic iron homeostasis. Iron regulates hepcidin by activating bone morphogenetic protein (BMP)6 expression in liver endothelial cells (LECs), but the mechanisms are incompletely understood. To address this, we performed proteomics and RNA-sequencing on LECs from iron-adequate and iron-loaded mice. Gene set enrichment analysis identified transcription factors activated by high iron, including Nrf-2, which was previously reported to contribute to BMP6 regulation, and c-Jun. (encoding c-Jun) knockdown blocked but not Nrf-2 pathway induction by iron in LEC cultures. Chromatin immunoprecipitation of mouse livers showed iron-dependent c-Jun binding to predicted sites in regulatory regions. Finally, c-Jun inhibitor blunted induction of and hepcidin, but not Nrf-2 activity, in iron-loaded mice. However, and iron parameters were unchanged in endothelial knockout mice. Our data suggest that c-Jun participates in iron-mediated BMP6 regulation independent of Nrf-2, though the mechanisms may be redundant and/or multifactorial.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10730383PMC
http://dx.doi.org/10.1016/j.isci.2023.108555DOI Listing

Publication Analysis

Top Keywords

proteomics rna-sequencing
8
liver endothelial
8
endothelial cells
8
iron-loaded mice
8
bmp6 regulation
8
iron
6
c-jun
5
quantitative proteomics
4
rna-sequencing mouse
4
mouse liver
4

Similar Publications

Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by reduced platelet levels and heightened susceptibility to bleeding resulting from augmented autologous platelet destruction and diminished thrombopoiesis. Although antibody-mediated autoimmune reactions are widely recognized as primary factors, the precise etiological agents that trigger ITP remain unidentified. The pathogenesis of ITP remains unclear owing to the absence of comprehensive high-throughput data, except for the belated emergence of autoreactive antibodies.

View Article and Find Full Text PDF

METTL3-Mediated m6A Modification of ISG15 mRNA Regulates Doxorubicin-Induced Endothelial Cell Apoptosis.

J Cell Mol Med

January 2025

Zhengzhou Key Laboratory of Cardiovascular Aging, Henan Province Key Laboratory for Prevention and Treatment of Coronary Heart Disease, National Health Commission key Laboratory of Cardiovascular Regenerative Medicine, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital & Central China Branch of National Center for Cardiovascular Diseases, Zhengzhou, Henan, China.

N6-adenosine methylation (m6A) of RNA is involved in the regulation of various diseases. However, its role in chemotherapy-related vascular endothelial injury has not yet been elucidated. We found that methyltransferase-like 3 (METTL3) expression was significantly reduced during doxorubicin (DOX)-induced apoptosis of vascular endothelial cells both in vivo and in vitro, and that silencing of METTL3 further intensified this process.

View Article and Find Full Text PDF

Background: Central nervous system (CNS) dysregulated insulin and peripheral hyperinsulinemia has been associated with AD. However, analyzing CNS insulin resistance in living subjects and its implication on cognitive impairment/ AD is difficult to establish due to inaccessibility of brain tissue. In this study we isolated and characterized plasma neuron‐derived small extracellular vesicles (NDE), and adopted multi‐omics approaches to discover novel biomarkers of AD and CNS insulin resistance and suggested their possible association.

View Article and Find Full Text PDF

Background: The choroid plexus (ChP) is formed by epithelial cells and stromal fibroblasts which act as a blood‐cerebrospinal fluid (CSF) barrier, play a key role in maintaining brain homeostasis, and provide a niche for immune cells. ChP dysfunction has been implicated in Alzheimer’s Disease (AD), including changes in CSF secretion, increased apoptosis, and dysregulated immune, mitochondrial, and transporter functions.

Method: Here, we performed single‐nuclei RNA‐Sequencing (snRNA‐Seq) on 965,647 ChP nuclei from 68 ROSMAP participants with no cognitive impairment (NCI), mild cognitive impairment (MCI) or Alzheimer’s Dementia (ADem).

View Article and Find Full Text PDF

Background: Evidence suggests glucagon‐like peptide 1 receptor agonists (GLP‐1RAs) may have therapeutic potential in Alzheimer’s disease (AD). Cumulative evidence has indicated a potential reduction in cognitive decline in people with AD, while real‐world evidence has shown decreased dementia risk in patients with type 2 diabetes. Non‐clinical data reveal that GLP‐1RAs impact neuroinflammation and other biological processes believed to be involved in AD pathophysiology, including effects on central and peripheral immune cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!